PRESERVATION OF HYPOTHALAMIC DOPAMINERGIC-NEURONS IN PARKINSONS-DISEASE

被引：82
|
作者：
MATZUK, MM
SAPER, CB
机构：
[1] WASHINGTON UNIV,SCH MED,DEPT NEUROL & NEUROL SURG NEUROL,ST LOUIS,MO 63110
[2] WASHINGTON UNIV,SCH MED,DEPT ANAT & NEUROBIOL,ST LOUIS,MO 63110
来源：
ANNALS OF NEUROLOGY | 1985年 / 18卷 / 05期
关键词：
D O I：
10.1002/ana.410180507
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：552 / 555
页数：4
相关论文
共 50 条
  • [31] FAILURE OF A PERIPHERAL DOPAMINERGIC MARKER IN PARKINSONS-DISEASE
    MALOTEAUX, JM
    LATERRE, CE
    HENS, L
    LADURON, PM
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1983, 46 (12): : 1146 - 1148
  • [32] DOPAMINERGIC RECEPTOR ACTIVITY IN PARKINSONS-DISEASE AND SCHIZOPHRENIA
    RIEDERER, P
    JELLINGER, K
    GABRIEL, E
    JOURNAL OF CLINICAL CHEMISTRY AND CLINICAL BIOCHEMISTRY, 1982, 20 (09): : 643 - 643
  • [33] LYMPHOCYTE DOPAMINERGIC RECEPTORS AND IDIOPATHIC PARKINSONS-DISEASE
    LEFUR, G
    MEININGER, V
    BAULAC, M
    PHAN, T
    UZAN, A
    REVUE NEUROLOGIQUE, 1980, 136 (12) : 891 - 891
  • [34] AN ENDOGENOUS DOPAMINERGIC NEUROTOXIN - IMPLICATION FOR PARKINSONS-DISEASE
    MATTAMMAL, MB
    HARING, JH
    CHUNG, HD
    RAGHU, G
    STRONG, R
    NEURODEGENERATION, 1995, 4 (03): : 271 - 281
  • [35] ACTIVITY OF HYPOTHALAMIC DOPAMINERGIC-NEURONS IN RELATION TO BLOOD-PRESSURE
    ELGHOZI, JL
    EARNHARDT, JT
    LEQUANBUI, KH
    DEVYNCK, MA
    MEYER, P
    CONTRIBUTIONS TO NEPHROLOGY, 1982, 30 : 31 - 37
  • [36] BRAIN GABA NEURONS IN PARKINSONS-DISEASE
    LAAKSONEN, H
    RINNE, UK
    SONNINEN, V
    RIEKKINEN, P
    ACTA NEUROLOGICA SCANDINAVICA, 1978, 57 : 282 - 283
  • [37] MOTOR RESPONSE TO REPEATED DOPAMINERGIC STIMULATION IN PARKINSONS-DISEASE
    OBESO, JA
    LUQUIN, MR
    GRANDAS, F
    VAAMONDE, J
    LAGUNA, J
    MARTINEZLAGE, JM
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (01) : 75 - 79
  • [38] BIOCHEMISTRY OF PARKINSONS-DISEASE WITH SPECIAL REFERENCE TO THE DOPAMINERGIC SYSTEMS
    HIRSCH, EC
    MOLECULAR NEUROBIOLOGY, 1994, 9 (1-3) : 135 - 142
  • [39] OPTIMUM SYMPTOMATIC CONTROL OF PARKINSONS-DISEASE WITH DOPAMINERGIC THERAPY
    BOUCHARD, S
    CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1987, 14 (03) : 460 - 465
  • [40] THE RATIONALE FOR CONTINUOUS DOPAMINERGIC STIMULATION IN PATIENTS WITH PARKINSONS-DISEASE
    SAGE, JI
    MARK, MH
    NEUROLOGY, 1992, 42 (01) : 23 - 28
12345